Clinical Trial Update: Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

View source ↗

Summary

An observational clinical trial from OncoHost Ltd. aims to predict responsiveness to anti-cancer treatments in patients with advanced cancers based on host resp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Stage Iiib-d Malignant Melanoma
• Unresectable Non-small Cell Lung Cancer

Snippet

Sponsor: OncoHost Ltd. | Conditions: Stage IV Non-small Cell Lung Cancer, Stage IV Malignant Melanoma | Status: ACTIVE_NOT_RECRUITING